Joshua Levine to Risk Factors
This is a "connection" page, showing publications Joshua Levine has written about Risk Factors.
Connection Strength
0.172
-
Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States. Curr Med Res Opin. 2022 Nov; 38(11):1785-1795.
Score: 0.101
-
SGLT2-I in the Hospital Setting: Diabetic Ketoacidosis and Other Benefits and Concerns. Curr Diab Rep. 2017 07; 17(7):54.
Score: 0.071